Issue |
J Extra Corpor Technol
Volume 15, Number 4, August 1983
|
|
---|---|---|
Page(s) | 104 - 108 | |
DOI | https://doi.org/10.1051/ject/1983154104 | |
Published online | 15 September 2023 |
Proceedings
Early Clinical Experiences with Terumo’s New Hollow Fiber Membrane Oxygenator: Capiox II
The Cleveland Clinic Foundation, Cleveland, Ohio
* Direct communications to: Martin Sinkewich, C.C.P., Cleveland Clinic Foundation, Department of Perfusion Services, 9500 Euclid Avenue, Cleveland, OH 44106
Terumo’s Capiox II is a hollow fiber membrane oxygenator with an integrated heat exchanger. This device is available in 1.6 m2, 3.3 m2, 4.3 m2, and 5.4 m2 sizes. Our clinical experiences have been with the 3.3 m2, 4.3 m2, and 5.4 m2 sizes, in over 150 open-heart patients. The 3.3 m2 was sized to patients up to 60 kg. The 5.4 m2 was used in all patients >60 kg. Both normothermic and hypothermic (24°-30° bladder) perfusions were performed. The heat exchanger was efficient and demonstrated structural integrity. On bypass, patient vital signs, gas and blood flows, arterial and venous blood gases and blood chemistries were monitored. Arterial saturations were 100%. Venous saturations were at least 65%. No acid-base problems were encountered. Initially, 100% oxygen was used. Later a gas blender using O2 and compressed air was utilized. Our experience concludes that the Capiox II is a safe, efficient onepump membrane oxygenator with integral heat exchanger. It is easy to set up and recirculate, delivering satisfactory oxygen transfer rates with a blended gas to blood flow ratio (≤1:1).
© 1983 AMSECT
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.